Our results further suggest that DNA 6mA modification serves as a new epigenetic mechanism in arsenic-induced skin carcinogenesis and may provide new insights into ALKBH4 and 6mA DNA methylation as potential novel therapeutic targets for the prevention and treatment of skin cancer in arsenic-exposed individuals. This evidence concerns the gene ALKBH4 and skin neoplasm.